Sunesis Pharmaceuticals, Inc. (NASDAQ: SNSS)

Sunesis Pharmaceuticals, Inc. (NASDAQ: SNSS), an emerging biopharmaceutical company, has focused their efforts on creating new medicines designed to improve the lives of patients diagnosed with cancer. The company is currently building a pipeline of drugs that selectively block vital mechanisms necessary for tumor growth and survival. Sunesis recognizes that the fight against cancer is an enormous mission that requires an integrated approach and innovation. For further information, visit the Company’s web site at www.sunesis.com.